GLP-3 RT
GLP-3 RT is a 39-amino acid triple agonist peptide studied for simultaneous GIP, GLP-1, and glucagon receptor activation. Additional glucagon receptor activity distinguishes it from dual agonists, enabling multi-pathway research into metabolic regulation and body composition.
Triple receptor co-agonism targets distinct metabolic pathways: GLP-1R agonism modulates appetite and glucose utilization; GIPR agonism enhances insulin sensitivity; glucagon receptor activity increases energy expenditure and hepatic glucose output β a comprehensive metabolic research profile.
Add bacteriostatic water slowly to the lyophilized powder. For 10mg vials: 1β2mL BW gives 5β10mg/mL. For 20mg vials: 2β4mL. Swirl gently. Refrigerate; use within 28 days. For long-term storage of unreconstituted peptide: -20Β°C recommended.
Verified Before it Reaches You.
Every Genix batch undergoes independent third-party testing. The CoA for this product is batch-specific β issued by the testing laboratory, not generated by Genix.
Research Grade Β· 99% Purity
Frequently Paired With
Researchers often combine GLP-3 RT with these compounds for multi-target protocols.
Frequently Asked Questions
Dual agonists target GIP + GLP-1 receptors. GLP-3 RT adds glucagon receptor co-agonism, introducing hepatic glucose regulation and energy expenditure pathways β a more comprehensive metabolic research profile.
Simultaneous activation of three GPCRs: GIP receptor (GIPR), GLP-1 receptor (GLP-1R), and glucagon receptor (GCGR). Each activates different downstream pathways relevant to metabolic regulation research.
Store lyophilized at -20Β°C for long-term. For short-term use (up to 3 months), 2β8Β°C is acceptable. Once reconstituted, use within 14β28 days. Avoid freeze-thaw cycles. Protect from light.
No. All Genix compounds are strictly for in vitro research and laboratory use only. Not for human or veterinary consumption.